7-30595081-A-G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_002047.4(GARS1):​c.160A>G​(p.Ser54Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000717 in 1,395,104 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Synonymous variant affecting the same amino acid position (i.e. S54S) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 7.2e-7 ( 0 hom. )

Consequence

GARS1
NM_002047.4 missense

Scores

1
1
16

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 2.24

Publications

0 publications found
Variant links:
Genes affected
GARS1 (HGNC:4162): (glycyl-tRNA synthetase 1) This gene encodes glycyl-tRNA synthetase, one of the aminoacyl-tRNA synthetases that charge tRNAs with their cognate amino acids. The encoded enzyme is an (alpha)2 dimer which belongs to the class II family of tRNA synthetases. It has been shown to be a target of autoantibodies in the human autoimmune diseases, polymyositis or dermatomyositis. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
GARS1-DT (HGNC:48951): (GARS1 divergent transcript)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_002047.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.112386584).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002047.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GARS1
NM_002047.4
MANE Select
c.160A>Gp.Ser54Gly
missense
Exon 1 of 17NP_002038.2P41250-1
GARS1
NM_001316772.1
c.-3A>G
5_prime_UTR
Exon 1 of 17NP_001303701.1P41250-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GARS1
ENST00000389266.8
TSL:1 MANE Select
c.160A>Gp.Ser54Gly
missense
Exon 1 of 17ENSP00000373918.3P41250-1
GARS1
ENST00000675651.1
c.160A>Gp.Ser54Gly
missense
Exon 1 of 17ENSP00000502513.1A0A6Q8PGZ8
GARS1
ENST00000675810.1
c.160A>Gp.Ser54Gly
missense
Exon 1 of 16ENSP00000502743.1A0A6Q8PHH9

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00000665
AC:
1
AN:
150340
AF XY:
0.0000122
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000162
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
7.17e-7
AC:
1
AN:
1395104
Hom.:
0
Cov.:
36
AF XY:
0.00000145
AC XY:
1
AN XY:
689640
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
32234
American (AMR)
AF:
0.00
AC:
0
AN:
37146
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25232
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36626
South Asian (SAS)
AF:
0.00
AC:
0
AN:
80218
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
35598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5642
European-Non Finnish (NFE)
AF:
9.22e-7
AC:
1
AN:
1084106
Other (OTH)
AF:
0.00
AC:
0
AN:
58302
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.375
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
33

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.11
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Benign
0.075
T
Eigen
Benign
-0.35
Eigen_PC
Benign
-0.17
FATHMM_MKL
Benign
0.55
D
LIST_S2
Benign
0.71
T
M_CAP
Benign
0.050
D
MetaRNN
Benign
0.11
T
MetaSVM
Benign
-0.72
T
PhyloP100
2.2
PrimateAI
Pathogenic
0.82
D
PROVEAN
Benign
-0.93
N
REVEL
Benign
0.21
Sift
Benign
0.20
T
Sift4G
Benign
0.38
T
PromoterAI
-0.014
Neutral
Varity_R
0.26
gMVP
0.29
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs1414091099;
hg19: chr7-30634697;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.